autologous tolerogenic dendritic cell vaccine (City of Hope)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameautologous tolerogenic dendritic cell vaccine (City of Hope)

Drug Alias NamePIpepTolDCautologous tolDCs vaccine (City of Hope)inverse vaccine (City of Hope)

ClassificationCell and gene therapy > Cell therapyVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Dendritic cell vaccine +[4]

Mechanisms of ActionVitamin D receptor agonists

TargetsVitamin D receptor

Therapy Area/IndicationsDiabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesNetherlands

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesCity of Hope

China Registration ClassN/A

Develop Information

Active CompaniesCity of Hope

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 1

Inactive IndicationsN/A

Other Information

ATC CodeN/A